SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Sunnova Energy International Inc. (NYSE: NOVA)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Sunnova Energy International Inc. (NYSE: NOVA)
PR Newswire
NEW YORK, March 27, 2024
NEW YORK, March 27, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Sunnova Energy International Inc. (NYSE: NOVA) on behalf of the company's shareholders. The investigation seeks to determine whether Sunnova Energy International's directors breached their fiduciary duties in connection with recent corporate actions.
If you are a shareholder of Sunnova Energy International Inc. and are interested in obtaining additional information about your rights and options, please visit us at: https://pjlfirm.com/sunnova-energy-international-inc/
You may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com or by telephone at 212-725-1000. One of our attorneys will personally speak with you about the case at no cost or obligation.
Purcell & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit https://pjlfirm.com. Attorney advertising. Prior results do not guarantee a similar outcome.
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-purcell--lefkowitz-llp-announces-shareholder-investigation-of-sunnova-energy-international-inc-nyse-nova-302100533.html
SOURCE Purcell & Lefkowitz LLP
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth